{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:26:02Z","timestamp":1777883162003,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["2022\\u20134 EXPL\/14795"],"award-info":[{"award-number":["2022\\u20134 EXPL\/14795"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202207720083"],"award-info":[{"award-number":["202207720083"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jsbmb.2026.106958","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T16:14:18Z","timestamp":1771172058000},"page":"106958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Review on 11-oxygenated steroids in hormone-related diseases: Polycystic ovary syndrome, endometrial cancer, prostate cancer"],"prefix":"10.1016","volume":"259","author":[{"given":"Xiaoman","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrica M.J.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5900-6883","authenticated-orcid":false,"given":"Andrea","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2026.106958_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41574-020-0336-x","article-title":"11-Oxygenated androgens in health and disease","volume":"16","author":"Turcu","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1210\/clinem\/dgae420","article-title":"Human gonads do not contribute to the circulating pool of 11-oxygenated androgens","volume":"110","author":"Charoensri","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2026.106958_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1404804","article-title":"T. Lani\u0161nik Ri\u017ener, Pre-receptor regulation of 11-oxyandrogens differs between normal and cancerous endometrium and across endometrial cancer grades and molecular subtypes","volume":"15","author":"Gjorgoska","year":"2024","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jsbmb.2026.106958_bib4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2026.106958_bib5","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa231","article-title":"11-Oxygenated Estrogens Are a Novel Class of Human Estrogens but Do not Contribute to the Circulating Estrogen Pool","volume":"162","author":"Barnard","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2026.106958_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.106049","article-title":"Bioactivity of 11 keto and hydroxy androgens in yeast and mammalian host cells","volume":"218","author":"Handelsman","year":"2022","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000528341","article-title":"11-oxygenated androgen metabolite concentrations are affected by pubertal progression and obesity","volume":"96","author":"Breslow","year":"2023","journal-title":"Horm. Res Paediatr."},{"key":"10.1016\/j.jsbmb.2026.106958_bib8","first-page":"4589","article-title":"11-ketotestosterone is the dominant circulating bioactive androgen during normal and premature adrenarche","volume":"103","author":"Rege","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2026.106958_bib9","first-page":"188","article-title":"Classic and 11-oxygenated androgens in serum and saliva across adulthood: a cross-sectional study analyzing the impact of age, body mass index, and diurnal and menstrual cycle variation","author":"Schiffer","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib10","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1210\/clinem\/dgaa343","article-title":"Sex differences in 11-oxygenated androgen patterns across adulthood","volume":"105","author":"Davio","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2026.106958_bib11","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1210\/jc.2018-02527","article-title":"11-oxygenated C19 steroids do not decline with age in women","volume":"104","author":"Nanba","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2026.106958_bib12","doi-asserted-by":"crossref","first-page":"e4509","DOI":"10.1210\/clinem\/dgab446","article-title":"Salivary profiles of 11-oxygenated androgens follow a diurnal rhythm in patients with congenital adrenal hyperplasia","volume":"106","author":"Nowotny","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2026.106958_bib13","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-21-0348","article-title":"Circadian rhythms of 11-oxygenated C19 steroids and \u22065-steroid sulfates in healthy men","volume":"185","author":"Turcu","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1210\/jcem-21-6-624","article-title":"Adrenal estrogens. I. Conversion of 4-C14-cortisone acetate to 11-oxygenated estrogens in women","volume":"21","author":"Chang","year":"1961","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2026.106958_bib15","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1093\/ejendo\/lvad047","article-title":"The clinical and biochemical significance of 11-oxygenated androgens in human health and disease","volume":"188","author":"Storbeck","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib16","article-title":"The role of 11-oxygenated androgens in prostate cancer","volume":"3","author":"Snaterse","year":"2023","journal-title":"Endocr. Oncol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1273542","article-title":"Androgen excess: a hallmark of polycystic ovary syndrome","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jsbmb.2026.106958_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2025.106747","article-title":"Production of 11-ketotestosterone in childhood adrenal tumors with virilization or peripheral precocious puberty: Dominant expression of 11beta-hydroxysteroid dehydrogenase type 2","volume":"251","author":"Fujisawa","year":"2025","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib19","doi-asserted-by":"crossref","first-page":"K39","DOI":"10.1530\/EJE-22-0508","article-title":"ACTH-independent production of 11-oxygenated androgens and glucocorticoids in an adrenocortical adenoma","volume":"187","author":"Kitamura","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib20","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaf172","article-title":"11-Oxygenated Androgens Inhibit Brown Adipose Tissue Differentiation","volume":"166","author":"Yuan","year":"2025","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2026.106958_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/1055-9965.EPI-20-0471","article-title":"The Steroid Metabolome and Breast Cancer Risk in Women with a Family History of Breast Cancer: The Novel Role of Adrenal Androgens and Glucocorticoids","volume":"30","author":"Houghton","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.jsbmb.2026.106958_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2025.109692","article-title":"Kobochromone A, a polyphenol in Carex kobomugi, suppresses androgen signaling induced by 11-oxygenated androgens and enhances the efficacy of AKT inhibitors in triple-negative breast cancer cells","volume":"223","author":"Tanio","year":"2025","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2026.106958_bib23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib24","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jsbmb.2026.106958_bib25","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jsbmb.2026.106958_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsbmb.2017.10.021","article-title":"Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery","volume":"178","author":"Audet-Delage","year":"2018","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2014.11.022","article-title":"The role of 5\u03b1-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma","volume":"401","author":"Tanaka","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMra1701695","article-title":"Metastatic Prostate Cancer","volume":"378","author":"Sartor","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jsbmb.2026.106958_bib29","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jsbmb.2026.106958_bib30","article-title":"E.G.C.E.a. clinicalguidelines@esmo.org, Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","author":"Walz","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5534\/wjmh.180040","article-title":"Role of Androgen Receptor in Prostate Cancer: A Review","volume":"37","author":"Fujita","year":"2019","journal-title":"World J. Mens. Health"},{"key":"10.1016\/j.jsbmb.2026.106958_bib32","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/JME-14-0203","article-title":"Androgens and androgen receptor signaling in prostate tumorigenesis","volume":"54","author":"Zhou","year":"2015","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping Studies: Towards a Methodological Framework","volume":"8","author":"Arksey","year":"2005","journal-title":"INT. J. SOC. RES. METHODOL. INT J. SOC RES METHODOL"},{"key":"10.1016\/j.jsbmb.2026.106958_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jsbmb.2026.106958_bib35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.jsbmb.2026.106958_bib36","unstructured":"G. Wells, B. Shea, D.O.'Connell, J. Peterson, V. Welch, M. Losos, P. Tugwell, The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis, (2000)."},{"key":"10.1016\/j.jsbmb.2026.106958_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.15171\/ijhpm.2014.71","article-title":"The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence","volume":"3","author":"Munn","year":"2014","journal-title":"Int J. Health Policy Manag"},{"key":"10.1016\/j.jsbmb.2026.106958_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/14737159.2025.2505546","article-title":"The discovery of biomarkers for endometrial cancer: update over the last years","volume":"25","author":"Ri\u017ener","year":"2025","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.jsbmb.2026.106958_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106366","article-title":"The serum steroid signature of PCOS hints at the involvement of novel pathways for excess androgen biosynthesis","volume":"233","author":"Altinkilic","year":"2023","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/JU.0000000000003049","article-title":"Preoperative circulating 11-oxygenated androgens are associated with metastasis-free survival in localized prostate cancer","volume":"209","author":"Dahmani","year":"2023","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/JU.0000000000004333","article-title":"High 11-ketotestosterone linked to shorter time to castration resistance in recurrent nonmetastatic prostate cancer","volume":"213","author":"Dahmani","year":"2025","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1156680","article-title":"Circulating adrenal 11-oxygenated androgens are associated with clinical outcome in endometrial cancer","volume":"14","author":"Dahmani","year":"2023","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jsbmb.2026.106958_bib43","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad079","article-title":"Interplay of cortisol, testosterone, and abdominal fat mass in normal-weight women with polycystic ovary syndrome","volume":"7","author":"Dumesic","year":"2023","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.jsbmb.2026.106958_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70022","article-title":"Exploring the predictive role of 11-oxyandrogens in diagnosing polycystic ovary syndrome","volume":"8","author":"Mody","year":"2025","journal-title":"Endocrinol. Diabetes Metab."},{"key":"10.1016\/j.jsbmb.2026.106958_bib45","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O'Reilly","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2026.106958_bib46","article-title":"11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration","volume":"6","author":"Snaterse","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jsbmb.2026.106958_bib47","doi-asserted-by":"crossref","first-page":"e2047","DOI":"10.1210\/clinem\/dgab920","article-title":"Clinical value of serum levels of 11-oxygenated metabolites of testosterone in women with polycystic ovary syndrome","volume":"107","author":"Tosi","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2026.106958_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179691","article-title":"The role of 11-oxygenated androgens and endocrine disruptors in androgen excess disorders in women","volume":"25","author":"Vitku","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2026.106958_bib49","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1507\/endocrj.EJ18-0212","article-title":"11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome","volume":"65","author":"Yoshida","year":"2018","journal-title":"Endocr. J."},{"key":"10.1016\/j.jsbmb.2026.106958_bib50","first-page":"17","article-title":"Multi-steroid profiling and machine learning reveal androgens as candidate biomarkers for endometrial cancer diagnosis: a case-control study","author":"Gjorgoska","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.jsbmb.2026.106958_bib51","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/humrep\/deae058","article-title":"Resumption of ovulation in anovulatory women with PCOS and obesity is associated with reduction of 11\u03b2-hydroxyandrostenedione concentrations","volume":"39","author":"Wang","year":"2024","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2026.106958_bib52","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/humrep\/dew252","article-title":"Effectiveness of lifestyle intervention in subgroups of obese infertile women: a subgroup analysis of a RCT","volume":"31","author":"van Oers","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2026.106958_bib53","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00592-024-02266-5","article-title":"Longitudinal assessment of classic and 11-oxygenated androgen concentrations and their association with type 2 diabetes mellitus development: the Troms\u00f8 study","volume":"61","author":"Allaoui","year":"2024","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/0ccac188-950f-4908-b232-35fb44ba7847","article-title":"The relationship between endogenous androgens and body fat distribution in early and late postmenopausal women","volume":"8","author":"Cao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2026.106958_bib55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1677\/ERC-07-0064","article-title":"Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"15","author":"Allen","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jsbmb.2026.106958_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1182479","article-title":"The impact of adipose tissue distribution on endometrial cancer: a systematic review","volume":"13","author":"Bosch","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib57","doi-asserted-by":"crossref","first-page":"T203","DOI":"10.1530\/ERC-13-0551","article-title":"Evidence of androgen action in endometrial and ovarian cancers","volume":"21","author":"Gibson","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jsbmb.2026.106958_bib58","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tem.2022.06.001","article-title":"Integration of androgen hormones in endometrial cancer biology","volume":"33","author":"Gjorgoska","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2026.106958_bib59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1530\/EJE-19-0905","article-title":"Abiraterone acetate treatment lowers 11-oxygenated androgens","volume":"182","author":"Wright","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib60","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mce.2016.08.014","article-title":"A new dawn for androgens: Novel lessons from 11-oxygenated C19 steroids","volume":"441","author":"Pretorius","year":"2017","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.106958_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105497","article-title":"The 11\u03b2-hydroxyandrostenedione pathway and C11-oxy C(21) backdoor pathway are active in benign prostatic hyperplasia yielding 11keto-testosterone and 11keto-progesterone","volume":"196","author":"du Toit","year":"2020","journal-title":"J. Steroid Biochem Mol. Biol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:35:57Z","timestamp":1777599357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076026000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":61,"alternative-id":["S0960076026000245"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.106958","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review on 11-oxygenated steroids in hormone-related diseases: Polycystic ovary syndrome, endometrial cancer, prostate cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.106958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106958"}}